Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 5, 2025Blood AdvancesOpen Access

Beyond Platelet Counts: Assessing Safety of Post-Splenectomy TPO-RA Use in ITP

View Full Paper
Ask AI
Bookmark
Share

Authors

RARuah AlyamanyDHDamon E. HoughtonMSMeera Sridharan

Discussion

Loading...

Member takes

Overview

Retrospective cohort study evaluates thrombosis incidence in ITP patients post-splenectomy, suggesting further research on TPO-RA implications.

Key Points

  • Thrombosis incidence was higher in the TPO-RA group, indicating potential risk factors in post-splenectomy patients.
  • Among patients, 42% were treated with TPO-RA, and thrombosis affected 17 in the TPO-RA group compared to 14 in the non-TPO-RA group.
  • This retrospective cohort study analyzed data from ITP patients who underwent splenectomy to determine safety outcomes.
  • Findings indicate a need for tailored thromboprophylaxis and further investigation into TPO-RA's safety after splenectomy.

Cite This Study

Alyamany et al. (2025) studied this question.

synapsesocial.com/papers/68bb3ef02b87ece8dc957559https://doi.org/10.1182/bloodadvances.2025017902
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Effect of thrombopoietin receptor agonists on markers of coagulation and P-selectin in patients with immune thrombocytopenia2017 · 38 citations
  2. 2Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group2008 · 2,706 citations
  3. 3Safety and efficacy of long-term treatment of chronic/persistent ITP with eltrombopag: final results of the EXTEND study2017 · 320 citations
  4. 4Thrombopoietin receptor agonists use and risk of thrombotic events in patients with immune thrombocytopenic purpura: A systematic review and meta‑analysis of randomized controlled trials2024 · 36 citations
  5. 5Thrombosis in patients with immune thrombocytopenia: incidence, risk, and clinical outcomes2024 · 25 citations